💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @PetterTrade | 10 |
| @TortozaLeandro | 6 |
| @A1Syad | 5 |
| @dailycandlestix | 5 |
| @Tickeron | 5 |
Recent Tweets for EXEL
 |
@hpaibot RT @AFtuit: Quality over all ? $EXEL Like ? ? #trading #YOLO #investments #wallstreetbets #RedditArmy #Stocks #daytrading #ToTheMoon #ne… January 25th 2022, 10:01pm |
 |
@TortozaLeandro $EXEL Awaiting for Short signal on EXEL with https://t.co/BVorhZSlcz https://t.co/n6m4R6TvpO January 25th 2022, 8:01pm |
|
@hpaibot RT @JimyTwits: Quality over all ? $EXEL Like ? ? #trading #YOLO #investments #wallstreetbets #RedditArmy #Stocks #daytrading #ToTheMoon… January 25th 2022, 8:01pm |
 |
@JimyTwits Quality over all ? $EXEL Like ? ? #trading #YOLO #investments #wallstreetbets #RedditArmy #Stocks #daytrading… https://t.co/QgJXXAvmNY January 25th 2022, 7:01pm |
 |
@AFtuit Quality over all ? $EXEL Like ? ? #trading #YOLO #investments #wallstreetbets #RedditArmy #Stocks #daytrading… https://t.co/LLyz3R5ZVJ January 25th 2022, 7:01pm |
 |
@TradeWithAlerts Nice print for $EXEL Size: 200000 Price: 18.125 Amount: $3,625,000.00 Time: 1304 See more: https://t.co/WzjaQSaXvC… https://t.co/yM8hp5UlBr January 25th 2022, 6:01pm |
 |
@prosperousguy @ChartingOptions I have had the thought (truthfully for over a year) that $EXEL does have a good drug, but also has… https://t.co/Y0srZt6zuX January 25th 2022, 5:01pm |
 |
@msshortcut89 $exel strong and interesting options volume. What’s going on? January 25th 2022, 4:01pm |
 |
@trndtrader $EXEL BULL FLOW January 25th 2022, 4:01pm |
 |
@BioWino RT @WallStJesus: $EXEL BULL FLOW January 25th 2022, 4:01pm |
 |
@allincapital woah $EXEL been awhile since this saw any flow. buyout? https://t.co/nIaIbLvg1S January 25th 2022, 4:01pm |
|
@TradeWithAlerts Nice print for $EXEL Size: 118484 Price: 17.98 Amount: $2,130,342.32 Time: 1110 See more: https://t.co/WzjaQSaXvC J… https://t.co/y0TePf6FTJ January 25th 2022, 4:01pm |
|
@TradeWithAlerts Nice print for $EXEL Size: 200000 Price: 17.93 Amount: $3,586,000.00 Time: 955 See more: https://t.co/WzjaQRTmE4 Jo… https://t.co/kNA2wfwEFA January 25th 2022, 2:01pm |
 |
@PetterTrade $EXEL Waiting for Short signal on EXEL https://t.co/6p1mFQLIBp January 25th 2022, 1:01pm |
|
@PetterTrade $EXEL Waiting for Short signal on EXEL https://t.co/X0slP2pD9z January 24th 2022, 10:01pm |
 |
@JoseRestonVA Nice reversal - hoping for some continuation. Portfolio intact. Only trade these days was $EXEL on Friday, which is working nice so far January 24th 2022, 9:01pm |
 |
@Tickeron $EXEL's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/m6dZJ7i1Uf January 24th 2022, 8:01pm |
 |
@ironicpoor RT @SeekingAlpha: $EXEL - Exelixis (EXEL) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference. https://t.co/mD1CifURza #stock… January 24th 2022, 7:01pm |
 |
@SeekingAlpha $EXEL - Exelixis (EXEL) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference. https://t.co/mD1CifURza… https://t.co/EOj4uj3ZCZ January 24th 2022, 7:01pm |
 |
@A1Syad $EXEL Waiting for Buy signal. Chart by https://t.co/1MjnDHV7ua https://t.co/tXwmoqBXju January 24th 2022, 5:01pm |
|
@TradeWithAlerts Nice print for $EXEL Size: 175000 Price: 17.69 Amount: $3,095,750.00 Time: 1141 See more: https://t.co/WzjaQSaXvC J… https://t.co/lSokt4PWjY January 24th 2022, 4:01pm |
|
@TortozaLeandro $EXEL Awaiting for Buy signal on EXEL with https://t.co/BVorhZSlcz https://t.co/goTM0YK737 January 24th 2022, 3:01pm |
 |
@MercurialCharts @qcapital2020 Some biotechs have held up well recently - $EXEL hasn't been moving much January 24th 2022, 3:01pm |
 |
@3ricdudley $EXEL green will it break above resistance https://t.co/pA6qS23bsH January 24th 2022, 2:01pm |
 |
@invescent $EXEL Data indicates that the overall analyst sentiment for EXEL is neutral Simplify the way you research stocks… https://t.co/gAGe3H6f9A January 24th 2022, 1:01pm |
 |
@MaiteMerenda $EXEL Awaiting Buy Signal. Chart by https://t.co/t5kOjgsWN3 https://t.co/sQfnlXNPxL January 24th 2022, 11:01am |
 |
@ShortAlgoKing $EXEL Watching for Buy Signal. Chart by https://t.co/qchl9O5K2n https://t.co/KsJ5n74wOZ January 23rd 2022, 12:01pm |
|
@invescent $EXEL Data indicates that the overall analyst sentiment for EXEL is bearish. Simplify the way you research stock… https://t.co/tmsKr33iOP January 22nd 2022, 3:01am |
 |
@dailycandlestix $EXEL Engulfing Daily appearances since 2010: 89 Close 5 days later ±: Avg: -0.02 SD: 1.07 Worst: -2.93 Best: 4.08… https://t.co/36CMtEfycO January 21st 2022, 9:01pm |
 |
@z7rw85jjgd $exel why so strong in this tape? January 21st 2022, 8:01pm |
|
@TortozaLeandro $EXEL Awaiting for Buy signal on EXEL with https://t.co/BVorhZSlcz https://t.co/s3AaWmam3i January 21st 2022, 8:01pm |
|
@JoseRestonVA @lblegend33 Some of the commercial-stage small/mid bios are performing decent/well. Got some $EXEL. Only trade I made today. January 21st 2022, 8:01pm |
|
@JoseRestonVA Bought some $EXEL - showing signs of life January 21st 2022, 8:01pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/cSypLUjvmf January 21st 2022, 2:01pm |
|
@dailycandlestix $EXEL Minor Breakdown Daily appearances since 2010: 157 Close 5 days later ±: Avg: 0.13 SD: 0.93 Worst: -1.95 Best:… https://t.co/SCwzmYLsZ3 January 20th 2022, 9:01pm |
|
@TradeWithAlerts Nice print for $EXEL Size: 186008 Price: 17.03 Amount: $3,167,716.24 Time: 1600 See more: https://t.co/WzjaQSaXvC J… https://t.co/zJpkzljEH1 January 20th 2022, 9:01pm |
|
@A1Syad $EXEL Bullish pattern forming. Chart by https://t.co/1MjnDIcIlI https://t.co/5YDoNks3RE January 20th 2022, 6:01pm |
 |
@ChartMill $EXEL was analyzed by 20 analysts. The buy consensus is at 82%. So analysts seem to be very confident about $EXEL.… https://t.co/gVOxtjug8s January 20th 2022, 5:01pm |
|
@PetterTrade $EXEL Waiting for buy signal on EXEL https://t.co/SMmFgDRUyS January 20th 2022, 2:01pm |
|
@dailycandlestix $EXEL Minor Breakdown Daily appearances since 2010: 157 Close 5 days later ±: Avg: 0.13 SD: 0.93 Worst: -1.95 Best:… https://t.co/hgCTUOj795 January 19th 2022, 9:01pm |
|
@PetterTrade $EXEL Waiting for buy signal on EXEL https://t.co/cRL57ZutIL January 19th 2022, 12:01pm |
 |
@StckPro $EXEL NEW ARTICLE : Exelixis (EXEL) Gets a Buy Rating from H.C. Wainwright https://t.co/YqpyneU0oF Get all the late… https://t.co/J7VouyIsHK January 19th 2022, 11:01am |
 |
@MarcJacksonLA $EXEL Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Adv… https://t.co/hojLbxXOxG January 19th 2022, 1:01am |
|
@ironicpoor RT @Tickeron: $EXEL enters a Downtrend because Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for this and othe… January 19th 2022, 12:01am |
|
@Tickeron $EXEL enters a Downtrend because Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for thi… https://t.co/cngqY3X8ov January 19th 2022, 12:01am |
 |
@PreventiveBot RT @ExelixisInc: Just announced: Detailed results from two trials of $EXEL flagship therapy in combination with immunotherapies in patients… January 18th 2022, 10:01pm |
 |
@ExelixisInc Just announced: Detailed results from two trials of $EXEL flagship therapy in combination with immunotherapies in p… https://t.co/Ktdbzqkn7D January 18th 2022, 10:01pm |
 |
@otcdynamics $EXEL Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Adv… https://t.co/c7nfCxWC45 January 18th 2022, 10:01pm |
 |
@phasefivebot $EXEL Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Adv… https://t.co/JQe0wu3348 January 18th 2022, 10:01pm |
 |
@StockNewsBot2 $EXEL Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Adv… https://t.co/zguBUIqdYX January 18th 2022, 10:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?